ELDN

$2.62+0.00%visit website

Eledon Pharmaceuticals, Inc.

Market Cap

$213M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.98

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

6.4

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	14,969	17,491	17,197	18,230	67,887
Total operating expenses	19,070	21,484	21,181	22,869	84,604
Operating income	(19,070)		(21,181)	(22,869)
Net income	(17,459)	(10,447)	(39,025)	(31,630)	(98,561)
EPS (basic) ($)	(0.21)		(0.33)	(0.27)	(0.90)
EPS (diluted) ($)	(0.21)		(0.33)	(0.27)	(0.90)
Weighted avg. shares (basic)	77,156		112,424	113,632
Weighted avg. shares (diluted)	77,156		112,424	113,632

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 50 more quarters, back to Mar 2013, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 13, 2026 accepted 4:08 PM ET	2.02Earnings release	Document SEC ↗
Jun 22, 2026 accepted 5:00 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
May 13, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
Mar 19, 2026 accepted 5:02 PM ET	2.02Earnings release	Document SEC ↗
Jan 2, 2026 accepted 4:30 PM ET	3.02Unregistered equity sale	Document SEC ↗
Nov 14, 2025 accepted 5:11 PM ET	2.02Earnings release	Document SEC ↗
Nov 13, 2025 accepted 8:55 PM ET	1.01Material agreement	Document SEC ↗
Nov 7, 2025 accepted 6:44 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 14, 2025 accepted 4:30 PM ET	2.02Earnings release4.02Non-reliance (restatement)	Document SEC ↗
Aug 6, 2025 accepted 4:03 PM ET	7.01Reg FD disclosure	Document SEC ↗